Authored book

Costing guidelines for tuberculosis interventions

Publication Details

Author list: Cunnama L, Garcia Baena I, Gomez G, Laurence Y, Levin C, Siapka M, Sweeney S, Vassall A, Sinanovic E

Publisher: World Health Organization

Publication year: 2019

Start page: 1

End page: 124

Total number of pages: 124

ISBN: 978-92-4-000009-4



Background Substantial progress has been made in the past decade to improve tuberculosis (TB) outcomes and control, particularly with the development and implementation of new diagnostic tests and treatment regimens [1–3]. Addressing the global TB epidemic is in line with the goals of Universal Health Coverage (UHC) to provide health care for all, without financial adversity. However, funding for TB still needs to be increased in order to reach global targets. Estimating the costs of TB interventions is an essential component to planning, prioritizing and managing the funding of TB services [4]. The ‘Reference Case for Estimating the Costs of Global Health Services and Interventions’ [5] (referred to hereafter as the ‘Reference Case’) encourages consistent adherence to core principles when collecting data to estimate the costs of health services. As a guiding document, it also presents the different costing methodologies that can be utilized, indicating the strengths and weaknesses of each, and provides a set of principles to improve global health costing. In this set of guidelines, we draw on the Reference Case principles to outline the main steps for costing TB services. Researchers can develop specific protocols which draw from these steps depending on the purpose of their costing study. For example, cost methods may vary depending on the time available, size or scope of a study. Throughout this document, we use the Value TB Study as an illustration of how a TB costing study can be undertaken. Value TB was funded by The Bill and Melinda Gates Foundation ( The purpose of the Value TB Study was to assess the service delivery costs of all TB interventions in five countries (Kenya, Ethiopia, India, Philippines and Georgia) in order to update current data and inform users of the cost data, such as modellers and policy makers. The primary aim of Value TB was to enable National Tuberculosis Programmes (NTPs) and their funders to allocate their resources, both to and within TB, in an efficient and fair way. We also include a set of costing instruments called the Value TB Costing Tool Suite (including Data Collection and Data Entry components) which can be adapted depending on the costing protocol developed. The complementary Value TB Costing Tool Suite can be found on the Global Health Cost Consortium (GHCC) and World Health Organization (WHO) websites ( and en/), and a detailed explanation of these tools can be found in Appendix 8 of these guidelines.


Currently no objects available


Diseases, Economics, Tuberculosis

Last updated on 2020-21-09 at 15:56